Home > Healthcare > Medical Devices > Surgical Devices > Urinary Incontinence Treatment Devices Market

Urinary Incontinence Treatment Devices Market Trends

Report ID: GMI8190
Published Date: Feb 2024
Report Format: PDF

Download Free Sample

Urinary Incontinence Treatment Devices Market Trends

The consistent technological advancements in devices and surgical techniques have fuelled the demand for urinary incontinence treatment devices. Different technologies such as, ultrasound imaging, non-invasive wearable medical devices, and assistive electronic devices among others are supporting the industry growth.

Ongoing research and development efforts have resulted in innovative non-invasive wearable devices for urinary incontinence detection, such as sensor-based systems that enable continuous monitoring and early detection of urinary incontinence episodes. For instance, electronic components and sensors are sewed into underwear to identify urine incontinence and offer automated diaper warning systems. Thus, such advancements can be used to enhance urological conditions diagnosis and treatment.
Additionally, technological advancements in electrical stimulation device solutions for urology, aid in offering better control in continence care patients. For instance, the development of nerve stimulation devices by utilizing the Axonics modulation technology prevents accidental leakages as the device send a mild electric current to nerves in the lower back or the pelvic muscles that control urination.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market valuation of the urinary incontinence treatment devices was exceeded USD 3.1 billion in 2023 and is expected to reach around USD 6.5 billion by 2032, owing to the increasing prevalence of urinary incontinence (UI), growing incidence of prostate cancer, coupled with rise in target population base for urethral disorders.

The urethral slings segment was valued at over USD 1.5 billion in 2023 and will grow significantly through 2032 attributed to the rising demand for minimally invasive procedures globally.

North America urinary incontinence treatment devices industry accounted for USD 1 billion in 2023 and is predicted to witness substantial growth through 2032, owing to the awareness initiatives encouraging more people to seek medical attention.

Becton, Dickinson and Company, Boston Scientific Corporation, B Braun Melsungen AG, Caldera Medical Inc., Coloplast A/S, ConvaTec Group plc, Hollister Incorporated, Medtronic plc, PROMEDON GmbH, Teleflex Incorporated, and Zephyr Surgical Implants.